Geneva Partners’s Starbucks SBUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-41,014
Closed -$4.8M 114
2021
Q4
$4.8M Sell
41,014
-22,964
-36% -$2.59M 2.27% 15
2021
Q3
$7.06M Buy
63,978
+376
+0.6% +$44K 3.34% 6
2021
Q2
$7.11M Buy
63,602
+541
+0.9% +$61.2K 3.25% 7
2021
Q1
$6.89M Buy
63,061
+2,506
+4% +$263K 3.56% 7
2020
Q4
$6.48M Buy
+60,555
New +$5.78M 3.42% 5
2020
Q1
Sell
-48,014
Closed -$4.22M 73
2019
Q4
$4.22M Buy
48,014
+2,230
+5% +$190K 2.91% 11
2019
Q3
$4.05M Sell
45,784
-10,462
-19% -$970K 3.15% 9
2019
Q2
$4.71M Sell
56,246
-74
-0.1% -$5.8K 3.81% 3
2019
Q1
$4.19M Buy
56,320
+5,400
+11% +$371K 3.57% 3
2018
Q4
$3.28M Buy
+50,920
New +$3.19M 3.79% 8

Other funds holding SBUX

Geneva Partners's SBUX Position: Q1 2022 in Review

Geneva Partners sold out of Starbucks (SBUX) in Q1 2022, closing a stake of 41,014 shares — an estimated $4.8M sold.

Geneva Partners first reported a position in SBUX in Q4 2018 and held it in 10 quarters. The position peaked at $7.11M in Q2 2021. 2,272 funds tracked by Wall St. Rank hold SBUX as of Q1 2022.

  • Geneva Partners reported no remaining Starbucks position as of Q1 2022 after selling out during the quarter.
  • Geneva Partners sold 41,014 Starbucks shares in Q1 2022, an estimated $4.8M.
  • Geneva Partners first reported a position in Starbucks in Q4 2018 and held it in 10 quarters.
  • Geneva Partners's Starbucks position peaked at $7.11M in Q2 2021.
  • 2,272 funds tracked by Wall St. Rank held Starbucks as of Q1 2022.

Based on Geneva Partners's 13F filing for Q1 2022, filed 3 May 2022.